Erlotinib API

Holiness Pharmaceutical is a trusted and leading supplier and exporter of Erlotinib API, delivering high-quality oncology APIs to pharmaceutical companies across 40+ international markets. Erlotinib is a tyrosine kinase (EGFR) inhibitor widely used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer, positioning us as a reliable Erlotinib bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Erlotinib API manufacturers, offering high assay purity, stringent impurity control, excellent stability, and consistent process performance suitable for solid oral oncology formulations. Our expertise in targeted anticancer molecules makes us a dependable Pharmaceutical API exporter.

Our oncology API manufacturing facilities operate in strict compliance with international regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, tight impurity profiling, moisture and stability control, and pharmacopeial compliance for Erlotinib API.

We export Erlotinib API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing life-saving targeted cancer therapies. Holiness Pharmaceutical is widely trusted as a bulk Erlotinib API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter specializing in oncology APIs.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.